Lung cancer screening in the gulf: Rationale and recommendations

Sami M. Bennji*, B. Jayakrishnan, Adil H. Al-Kindi, Issa Al-Jahdhami, Zamzam Al-Hashami

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable to cure at the time of presentation. Therefore, the emphasis on lung cancer screening (LCS) is growing with the current evidence that has shown benefits with low-dose computed tomography scan of the chest in high-risk populations. LCS remains a debated topic in Gulf Cooperation Council (GCC) countries, possibly due to a lack of local experience. In this article, we explore the rationale and give recommendations on the best approach for LCS in GCC.

Original languageEnglish
Pages (from-to)189-192
Number of pages4
JournalAnnals of Thoracic Medicine
Issue number4
Publication statusPublished - Oct 1 2022


  • Low-dose computed tomography
  • Lung cancer
  • Lung cancer screening

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this